Daily Equity Reports 25 Jan 2019

1. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. CapitalStars Investment Adviser: SEBI Registration Number: INA000001647 DAILY EQUITY REPORT 25 THJANUARY 2019 Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

2. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. Daily Equity Report INDIAN FACE INDIAN MARKET CLOSE PREVIOUS ! INDIAN EQUITY BENCHMARK - Sensex ends on a high note, Nifty just below 10,850; Yes Bank surges 8%, At the close of market hours, the Sensex was up 86.63 points or 0.24% at NIFTY 36195.10, and the Nifty up 18.30 points or 0.17% at CLOSE PREVIOUS 10849.80. GLOBAL FACE NIKKEI ! 2145.03 2127.78 Asian Market - Asian markets finished mixed as of the most recent closing prices. The Hang Seng gained 0.42% and the SECTORIAL INDICES Shanghai Composite rose 0.41%. The Nikkei 225 lost 0.09%. CLOSE CHANGE (%) ! U.S. Market – North and South American markets finished mixed as of the most recent closing prices. The Bovespa CNX 100 0.13 S&P CNX 500 9072.20 0.04 gained 1.53% and the S&P 500 rose 0.22%. The IPC lost 0.20%. 4791.10 -0.10 CNX 200 5704.70 0.07 ! 0.06 European markets - European markets are mixed today. The CAC 40 is up 0.65% while the DAX gains 0.55%. The FTSE 100 is off 0.09%. TOP GAINERS CLOSE CHANGE (%) YESBANK RELIANCE 1,249.00 1.85 1,902.00 1.41 1.10 TOP LOSERS CLOSE CHANGE (%) -5.38 -2.61 UPL -1.95 3,784.00 -1.73 ULTRACEMCO Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

3. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. Daily Equity Report NIFTY SPOT MARKET MOVERS UPSIDE TREND BEARISH STRATEGY BUY ON DIPS SCRIPT CLOSE (%) 14.32 PIVOT POINTS 1.41 S3 10702 S2 10770 R1 10878 R2 10906 R3 10974 TCS 10810 10838 1.01 S1-10810 S2-10770 R1-10878 R2-10906 0.87 MARKET MOVERS DOWNSIDE CLOSE (%) -5.38 INFRATEL -1.95 BAJAJFINSV -1.13 -1.08 ONGC NET BUY (CR.) NET SELL (CR) STRATEGY BUY ON DIPS 3787.89 BEARISH PIVOT POINTS P 27303 DII 3222.18 S3 S1 27231 R1 R2 R3 27680 26925 27114 27420 27492 RESISTANCE NSE TOTALS ADVANCE BANK NIFTY S NIFTY BANK NIFTY 6 Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

4. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. Daily Equity Report MARKET TALKS ! ! Ravneet Gill appointed as Yes Bank MD & CEO; stock spikes ~15% CBI searches 4 locations under Videocon, Nupower loan sanction case Shares of ICICI Bank dropped 1% in noon trade on Thursday after a PTI report said that the CBI has conducted searches at four locations, including the offices of Videocon and Nupower. The companies are operated by former ICICI Bank CEO Chanda Kochhars husband Deepak in Mumbai. As per the report, the Central Bureau of Investigation (CBI) has also registered a first information report (FIR) in the case after conducting a preliminary inquiry. The bank landed in controversy after allegations were made that Chanda Kochhar, former ICICI Bank chief executive, had favored Videocon and strayed from following the bank lending practices. Videocons founders had an investment in a renewable energy company founded by Kochhars husband, Deepak. Yes Bank has received RBI approval for its new MD & CEO, Ravneet Singh Gill to join on or before March 1, 2019. Ravneet Gill, who is the CEO of Deutsche Bank India operations, will join the company on or before March 1, 2019. The bank posted a net profit of Rs1, 001cr for the third quarter ended December 2018. The net profit of the bank came at Rs1, 076.87cr in the corresponding quarter a year ago. ! Moody's upgrades IDBI's long-term senior unsecured ratings to Ba2; outlook changed to positive Moody's Investors Service upgrades the long-term foreign currency senior unsecured rating of IDBI Bank and its Dubai International Financial Centre (DIFC) Branch to Ba2 from B1. The long-term local and foreign currency bank deposit ratings of IDBI have been also upgraded to Ba2 from B1. IDBI Bank's Baseline Credit Assessment (BCA) has been upgraded to b2 from caa1. At the same time, the adjusted BCA is upgraded to b2 from caa1. ! Dr.Reddy's launches gDiprivan in US Dr.Reddy's Laboratories Ltd has announced the launch of Propofol Injectable Emulsion, USP, a therapeutic equivalent generic version of Diprivan (propofol) approved by the USFDA. "Dr.Reddy's is committed to providing affordable and innovative medicines for healthier lives. To that end, Dr. Reddy's neither condones nor supports the off-label use or misuse of its drugs," the company said in the filing. Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

5. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. Daily Equity Report NAME OF THE STOCK : YESBANK DATE : 25/01/2019 SEGMENT : CASH CHART TYPE : Candlestick EXCHANGE : NSE TECHNICAL INDICATORS USED : VOLUME.MACD,RSI. CHART INVESTMENT ADVICE: CALL CS CALL :- BUY YESBANK IN CASH ABOVE 216 TGT 221 SL 211 RATIONALE FOR ARRIVING INVESTMENT ADVICE : TECHNICAL VIEW : THE STOCK TECHINCALLY IS UP ,TAKING SUPPORT OF VOLUME.RESISTANCE IS BROKEN TODAY WITH HEAVY VOLUME.AS WELL AS A POSSIBILITY OF TREND REVERSAL IS THERE. OTHER REASON IF ANY :- SHOWING STRENGTHS IN INTRADAY CHARTS AS WELL. Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

6. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. DISCLAIMER The information and views in this report & all the service we provide are believed to be reliable, but we do not accept any responsibility for errors of fact or opinion. Investors have the right to choose the product/s that suits them the most. Sincere efforts have been made to present the right investment perspective. The information contained herein is based on analysis and up on sources that we consider reliable. This material is for personal information and based upon it & takes no responsibility. The information given herein should be treated as only factor, while making investment decision. The report does not provide individually tailor-made investment advice. My research recommends that investors independently evaluate particular investments and strategies, and encourages investors to seek the advice of a financial adviser. Capitalstars shall not be responsible for any transaction conducted based on the information given in this report, which is in violation of rules and regulations of regulators. The price projections shown are not necessarily indicative of future price performance. The information herein, together with all estimates and forecasts, can change without notice. It is understood that anyone who is browsing through the site has done so at his free will and does not read any views expressed as a recommendation for which either the site or its owners or anyone can be held responsible for. Investment & Trading in Securities Markets are always subjected to market risk. Capitalstars Financial Research Private Ltd., Reserves all Rights. INVESTMENT AND TRADING IN SECURITIES MARKET IS ALWAYS SUBJECTED TO MARKET RISK. Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

7. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. CapitalStars Financial Research Private Limited is an advisory company incepted with a vision of providing fair and accurate trading and investment calls in share and commodity market. we specialize in thorough fundamental and technical research analysis in equity and commodity market to provide best equity and commodity tips to traders and investors. we provide intraday as well as delivery stock tips in NSE and BSE and commodity tips in MCX and NCDEX. Get our more services:- Intraday stock tips Financial advisory company Share market company Stock Tips * Investment & Trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance. * CapitalStars Investment Adviser: SEBI Registration Number: INA000001647

8. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. BRANCH OFFICE Capitalstars Financial Research Private Limited PLOT NO.32, MECHANIC NAGAR EXTENSION,IDA SCHEME NO.54,VIJAYNAGAR INDORE REGISTERED OFFICE PLOT NO.12, SCHEME NO.78 PART-2, VIJAY NAGAR, INDORE Email:-backoffice@capiltalstars.in Contact us :- 9977499927, 9039012727 Report Is Checked by Investment Advisor: Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.